Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
OptionableOptionable
Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions
What is Inspire Medical Systems' stock symbol?
Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."
How were Inspire Medical Systems' earnings last quarter?
Inspire Medical Systems (NASDAQ:INSP) posted its quarterly earnings data on Tuesday, November, 6th. The company reported ($0.22) EPS for the quarter, topping the Zacks' consensus estimate of ($0.35) by $0.13. The company had revenue of $13.10 million for the quarter, compared to the consensus estimate of $12.86 million. Inspire Medical Systems's revenue was up 79.9% on a year-over-year basis. During the same quarter last year, the business earned ($3.42) EPS. View Inspire Medical Systems' Earnings History.
When is Inspire Medical Systems' next earnings date?
What guidance has Inspire Medical Systems issued on next quarter's earnings?
Inspire Medical Systems issued an update on its FY 2018 earnings guidance on Tuesday, November, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $47.5-48 million, compared to the consensus revenue estimate of $44.17 million.
What price target have analysts set for INSP?
7 analysts have issued 12-month price objectives for Inspire Medical Systems' stock. Their predictions range from $25.00 to $57.00. On average, they expect Inspire Medical Systems' stock price to reach $38.4286 in the next twelve months. This suggests that the stock has a possible downside of 28.3%. View Analyst Price Targets for Inspire Medical Systems.
What is the consensus analysts' recommendation for Inspire Medical Systems?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inspire Medical Systems.
Has Inspire Medical Systems been receiving favorable news coverage?
News articles about INSP stock have trended somewhat positive on Thursday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Inspire Medical Systems earned a daily sentiment score of 1.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days.
Who are some of Inspire Medical Systems' key competitors?
Some companies that are related to Inspire Medical Systems include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Anteo Diagnostics (ADO), Aurora Spine (ASG), Avacta Group (AVCT), Azure Healthcare (AZV), Cannabix Technologies (BLOZF), Cochlear (COH), ConvaTec Group (CTEC), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Electromed (ELMD), Ellex Medical Lasers (ELXMF) and EMvision Medical Devices (EMV).
Who are Inspire Medical Systems' key executives?
Inspire Medical Systems' management team includes the folowing people:
- Mr. Tim Herbert, Chief Exec. Officer and Pres
- Mr. Richard Buchholz, Chief Financial Officer
- Mr. Randy Ban, Sr. VP of Sales and Marketing
- Mr. Sean Cleary, VP of Global Market Devel.
- Mr. Gary A. Goetzke, VP of Health Economics
When did Inspire Medical Systems IPO?
(INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.
Who are Inspire Medical Systems' major shareholders?
Inspire Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Arcadia Investment Management Corp MI (0.00%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Jerry C Griffin, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.
Which institutional investors are buying Inspire Medical Systems stock?
INSP stock was purchased by a variety of institutional investors in the last quarter, including Arcadia Investment Management Corp MI. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
How do I buy shares of Inspire Medical Systems?
Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Inspire Medical Systems' stock price today?
One share of INSP stock can currently be purchased for approximately $53.60.
What is Inspire Medical Systems' official website?
MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
